Design, synthesis and evaluation of D-galactose-beta-cyclodextrin conjugates as drug-carrying molecules

Bioorg Med Chem. 2008 Oct 1;16(19):8830-40. doi: 10.1016/j.bmc.2008.08.076. Epub 2008 Sep 3.

Abstract

Several kinds of D-galactose-beta-cyclodextrin conjugates having a phenyl group in the spacers between the D-galactose and beta-cyclodextrin were designed and synthesized as drug-carrying molecules. Their evaluation as drug-carrying molecules was done by measuring the molecular interactions with the anticancer agent, doxorubicin, and with the d-galactose-binding peanut lectin using an SPR optical biosensor. The SPR analyses showed that these conjugates had remarkably high inclusion associations of 10(5) approximately 10(7)M(-1) levels for the immobilized doxorubicin. Their association constants for immobilized peanut lectin were at the level of 10(4) approximately 10(5)M(-1), as we expected. These conjugates will be useful drug-carrying models which can site-specifically carry doxorubicin to the cells containing D-galactose-binding lectin.

Publication types

  • Evaluation Study

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism
  • Binding Sites
  • Biosensing Techniques / methods
  • Doxorubicin / chemistry
  • Doxorubicin / metabolism
  • Drug Carriers / chemical synthesis
  • Drug Carriers / pharmacology*
  • Drug Delivery Systems / methods*
  • Drug Design*
  • Galactose / analogs & derivatives
  • Galactose / chemical synthesis
  • Galactose / pharmacology*
  • Peanut Agglutinin / chemistry
  • Peanut Agglutinin / metabolism
  • Structure-Activity Relationship
  • Surface Plasmon Resonance / methods
  • beta-Cyclodextrins / chemical synthesis
  • beta-Cyclodextrins / pharmacology*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Peanut Agglutinin
  • beta-Cyclodextrins
  • Doxorubicin
  • Galactose